Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The immune microenvironment in MDS-to-AML transformation: dynamic ecological remodeling and therapeutic implications.

Created on 19 Nov 2026

Authors

Zhangbiao Long, Ruiqiu Wu, Shumin Yuan, Kaibo Yang, Tianle Cheng, Bing Han, Jichun Yang

Published in

Biomarker research. Volume 14. Issue 1. Nov 18, 2026. Epub Nov 18, 2026.

Abstract

Myelodysplastic neoplasms (MDS) are clonal myeloid neoplasms characterized by ineffective hematopoiesis, cytopenias, and a variable risk of transformation to Acute myeloid leukemia (AML). Although genetic lesions are central to MDS pathogenesis, progression to AML cannot be explained by mutation accumulation alone. This review synthesizes evidence that MDS-to-AML transformation is a dynamic ecological process driven by reciprocal interactions between mutant hematopoietic stem and progenitor cell clones and the bone marrow immune microenvironment. In normal marrow, hematopoietic stem and progenitor cells, T cells, NK(natural killer) cells, myeloid cells, mesenchymal stromal cells, endothelial cells, and the extracellular matrix maintain hematopoietic homeostasis and immune surveillance. In MDS, chronic inflammation coexists with impaired immune effector function, including T-cell exhaustion, reduced NK-cell cytotoxicity, expansion of myeloid-derived suppressor cells and immunosuppressive regulatory T-cell subsets, monocyte-macrophage reprogramming, mesenchymal stromal cell dysfunction, extracellular matrix remodeling, and metabolic adaptation. Together, these alterations establish a proinflammatory but immunosuppressive niche that weakens clearance of abnormal clones while providing stromal and metabolic support for clonal expansion and treatment resistance. Mutant clones further remodel the niche through epigenetic silencing, altered chemokine and cytokine signaling, and inflammatory-metabolic reprogramming, generating positive-feedback circuits that link inflammation, DNA damage, immune escape, increasing clonal burden, and therapy resistance. This review discusses how integrating clonal genetics with immune, stromal, and metabolic features may refine risk stratification and inform microenvironment-directed combination therapies. Longitudinal single-cell and spatial profiling will be essential for identifying reversible immune dysfunction and developing individualized strategies to delay or prevent AML transformation.

PMID:
43053160
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement